Translating the 2026 PE guideline recommendations into practice to enhance decision-making, streamline care pathways, and ...
A new guideline for acute pulmonary embolism developed by 10 major specialty societies introduces a novel PE clinical ...
MIAMI BEACH, FL—Pulmonary embolism (PE), an often-deadly condition that’s best served by a multidisciplinary approach to care, is the perfect target for artificial intelligence (AI), according to ...
SAN FRANCISCO--(BUSINESS WIRE)--Viz.ai, the leader in AI-powered disease detection and intelligent care coordination, today announced new clinical data supporting advancements in pulmonary embolism ...
Robert Lookstein, MD, co‑global principal investigator of the STORM‑PE, discusses newly released 90-day results.
MUNICH, Germany—Despite a dramatic rise in thrombectomy for pulmonary embolism (PE) in recent years, female patients in the United States with PE are less likely than their male peers to receive the ...
CAMBRIDGE, Mass., Nov. 1, 2023 /PRNewswire/ -- ConcertAI's TeraRecon, a leader in advanced visualization and AI Clinical SaaS, is pleased to announce an expanded collaboration with Avicenna.AI, a ...
Rapidai Inc. Received U.S. FDA 510(k) clearance for Rapid RV/LV, the latest addition to its pulmonary embolism (PE) solution. Rapid RV/LV uses artificial intelligence to quickly calculate the right ...
The ALPHA-PE Research Fund Supports Independent, Physician-Led Studies to Advance Real-World PE Evidence The ALPHA-PE Research Fund is designed to support independent, physician-led research ...
LATHAM, N.Y., February 05, 2026--(BUSINESS WIRE)--AngioDynamics, Inc. (NASDAQ: ANGO), a leading and transformative medical technology company focused on restoring healthy blood flow in the body’s ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results